GreenMark Biomedical, Inc., an East Lansing, MI- and Ann Arbor, MI-based developer of patented nanoparticle-based dental technology, secured $670k in equity funding completing a $1.2m seed round.
The company intends to use funds to further develop and commercialize its technology.
The University of Michigan’s MINTS program, Invest Michigan and Red Cedar Ventures investments followed earlier funding from Blue Water Angels, Western Michigan University’s BRCC and Invest Detroit Ventures.
GreenMark develops a diagnostic product, which contains fluorescently labeled starch particles that target active caries and illuminate them using a standard curing light found in every dental practice. The identification at early stages before cavitation will allow the use of non-surgical management options, resulting in less discomfort and improved long-term oral health outcomes for patients.
It will be used by dental professionals as part of the routine dental exam.